These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29985715)

  • 21. How to manage postmenopausal osteoporosis?
    Body JJ
    Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches to the treatment of osteoporosis.
    Silva BC; Bilezikian JP
    Annu Rev Med; 2011; 62():307-22. PubMed ID: 21054170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer drug treatments: their effects on fracture prevention.
    Geusens P; Reid D
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):983-9. PubMed ID: 16301192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative risks for cancer associated with use of calcitonin, bisphosphonates or selective estrogen receptor modulators among osteoporosis patients: a population-based cohort study.
    Hsiao FY; Hsu WW
    Jpn J Clin Oncol; 2017 Oct; 47(10):935-941. PubMed ID: 28981741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates.
    Sousa IO; Diniz ET; Marques TF; Griz L; Coutinho Mde A; Bandeira F
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):244-9. PubMed ID: 20485916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic options in osteoporosis.
    Dominguez LJ; Scalisi R; Barbagallo M
    Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacotherapy and prevention of osteoporosis].
    Antelava NA; Antelava AV; Gongadze MV; Okudzhava MV; Pachkoriia KZ
    Georgian Med News; 2009; (172-173):80-8. PubMed ID: 19644198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs under development for osteoporosis ].
    Masuda H; Tanaka S
    Nihon Rinsho; 2009 May; 67(5):980-4. PubMed ID: 19432120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy.
    Silverman SL; Komm BS; Mirkin S
    Maturitas; 2014 Nov; 79(3):241-7. PubMed ID: 25124532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [[Antiresorptive agents in the treatment of osteoporosis].
    Novak S
    Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2008 Oct; 18(10):1483-92. PubMed ID: 18830046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in the treatment of osteoporosis.
    Eriksen EF; Halse J; Moen MH
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of pharmacotherapy of osteoporosis in cardiology patients.
    Zapolski T; Wysokiński A
    Cardiol J; 2010; 17(4):335-43. PubMed ID: 20690088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative Medical Management of Spine Surgery Patients With Osteoporosis.
    Lubelski D; Choma TJ; Steinmetz MP; Harrop JS; Mroz TE
    Neurosurgery; 2015 Oct; 77 Suppl 4():S92-7. PubMed ID: 26378362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New management options for osteoporosis with emphasis on SERMs.
    McClung MR
    Climacteric; 2015; 18 Suppl 2():56-61. PubMed ID: 26503459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developments in the pharmacotherapeutic management of osteoporosis.
    Close P; Neuprez A; Reginster JY
    Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.